Connectus Wealth, LLC Amgen Inc Transaction History

Connectus Wealth, LLC

$4.37 Billion
Q1 2024

A detailed history of Connectus Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Connectus Wealth, LLC holds 5,787 shares of AMGN stock, worth $1.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,787

Previous 6,904 16.18%

Holding current value

$1.8 Million

Previous $1.99 Million 17.25%

% of portfolio

0.04%

Previous 0.04%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $300,327 - $362,533	-1,117 Reduced 16.18%	5,787 $1.65 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $428,808 - $483,747	-1,677 Reduced 19.54%	6,904 $1.99 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $227,833 - $282,861	1,042 Added 13.82%	8,581 $2.31 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $14,141 - $16,722	-66 Reduced 0.87%	7,539 $1.67 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $312,041 - $380,326	1,382 Added 22.21%	7,605 $1.84 Million

Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $86,115 - $109,419	-376 Reduced 5.7%	6,223 $1.63 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $47,361 - $53,414	211 Added 3.3%	6,599 $1.49 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $321,840 - $358,152	1,395 Added 27.94%	6,388 $1.56 Million
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $2.72 Million - $3.01 Million	-12,410 Reduced 71.31%	4,993 $1.12 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $3.46 Million - $3.96 Million	17,403 New	17,403 $3.92 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connectus Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connectus Wealth, LLC with notifications on news.

Account

Connectus Wealth, LLC Amgen Inc Transaction History